Literature DB >> 19808350

Value of exercise treadmill testing in the risk stratification of patients with pulmonary hypertension.

Sanjiv J Shah1, Thenappan Thenappan, Stuart Rich, James Sur, Stephen L Archer, Mardi Gomberg-Maitland.   

Abstract

BACKGROUND: The ability of the Naughton-Balke exercise treadmill test, an objective indicator of exercise capacity, to predict abnormal hemodynamics and mortality in pulmonary hypertension is unknown. METHODS AND
RESULTS: We performed a cohort study of 603 patients with pulmonary hypertension from 1982 to 2006, and studied the utility of exercise treadmill test as a predictor of abnormal hemodynamics and death. We used multivariable linear regression to determine whether exercise capacity, measured in metabolic equivalents, was associated with abnormal hemodynamics, and we used a Cox proportional hazards model to determine whether decreased exercise capacity predicted death. Mean age was 50+/-15 years, 76% were women, 63% had World Health Organization category I pulmonary arterial hypertension, and 23% were World Health Organization functional classes I and II. Mean exercise capacity was 3.7+/-2.2 metabolic equivalents. Decreased exercise capacity was independently associated with elevated right atrial and mean pulmonary artery pressure, decreased cardiac index, and increased pulmonary vascular resistance. During median follow-up of 4.6 years, 36% of the patients died. Decreased exercise capacity was associated with mortality (multivariable hazard ratio, 1.18; 95% CI, 1.01 to 1.37 for each 1-metabolic equivalent decrease in exercise capacity; P=0.031; P=0.052 after adjusting for invasive hemodynamic variables). Decreased exercise capacity also predicted mortality in functional classes I-II patients, 24% of whom died (hazard ratio, 1.53; 95% CI, 1.04 to 2.26 for each 1-metabolic equivalent decrease in exercise capacity; P=0.032), although this association did not persist after adjusting for invasive hemodynamic variables (P=0.63).
CONCLUSIONS: Reduced exercise capacity on exercise treadmill test is associated with worse hemodynamics and is a predictor of mortality in patients with pulmonary hypertension.

Entities:  

Mesh:

Year:  2009        PMID: 19808350     DOI: 10.1161/CIRCHEARTFAILURE.108.807826

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  13 in total

Review 1.  Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension.

Authors:  Benjamin H Freed; Amit R Patel; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

2.  Left Ventricular Function Before and After Aerobic Exercise Training in Women With Pulmonary Arterial Hypertension.

Authors:  Joshua G Woolstenhulme; Andrew A Guccione; Jeffrey E Herrick; John P Collins; Steven D Nathan; Leighton Chan; Randall E Keyser
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-03       Impact factor: 2.081

3.  Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension.

Authors:  Stuart Rich; Jennifer Pogoriler; Aliya N Husain; Peter T Toth; Mardi Gomberg-Maitland; Stephen L Archer
Journal:  Chest       Date:  2010-11       Impact factor: 9.410

Review 4.  Diagnosis and management of pulmonary hypertension in systemic sclerosis.

Authors:  Nadera J Sweiss; Linda Hushaw; Thenappan Thenappan; Ray Sawaqed; Roberto F Machado; Amit R Patel; Mardi Gomberg-Maitland; Aliya N Husain; Stephen L Archer
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

5.  Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension.

Authors:  Leighton Chan; Lisa M K Chin; Michelle Kennedy; Joshua G Woolstenhulme; Steven D Nathan; Ali A Weinstein; Gerilynn Connors; Nargues A Weir; Bart Drinkard; James Lamberti; Randall E Keyser
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

6.  Comprehensive Exercise Capacity and Quality of Life Assessments Predict Mortality in Patients with Pulmonary Arterial Hypertension.

Authors:  Yi-Jen Chen; Hung-Pin Tu; Chia-Ling Lee; Wei-Chun Huang; Jin-Shiou Yang; Cyuan-Fong Li; Chia-Hsin Chen; Ko-Long Lin
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

7.  Pulmonary arterial hypertension: an update.

Authors:  E S Hoendermis
Journal:  Neth Heart J       Date:  2011-12       Impact factor: 2.380

8.  Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.

Authors:  Benjamin H Freed; Mardi Gomberg-Maitland; Sonal Chandra; Victor Mor-Avi; Stuart Rich; Stephen L Archer; E Bruce Jamison; Roberto M Lang; Amit R Patel
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

9.  Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation.

Authors:  T Thenappan; S J Shah; S Rich; L Tian; S L Archer; M Gomberg-Maitland
Journal:  Eur Respir J       Date:  2009-12-23       Impact factor: 16.671

10.  The Evolution of Risk Assessment in Pulmonary Arterial Hypertension.

Authors:  Sandhya Murthy; Raymond Benza
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.